Results 11 to 20 of about 11,605 (196)

Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review [PDF]

open access: yesFrontiers in Oncology
Hairy cell leukemia variant (HCL-v) is a rare and more aggressive subtype of B-cell leukemia. While it shares certain clinical features with classical hairy cell leukemia (HCL-c), HCL-v typically follows a more malignant course and responds poorly to ...
Junjun Bai   +10 more
doaj   +2 more sources

Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report

open access: yesJournal of Medical Case Reports, 2018
Background Polycythemia vera is a myeloproliferative disease that sometimes evolves to myelofibrosis, causing splenomegaly and neutropenia. In this case report, we describe a patient with polycythemia vera and unexplained neutropenia who later turned out
Andreas Hanssønn Habberstad   +6 more
doaj   +1 more source

A Hairy Cell Leukaemia Variant – A Rare Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2013
The aim of the article is to present a rare case of Hairy cell leukaemia variant (HCl-V) which is a distinct clinico-pathological entity with intermediate features between classical HCl (HCl-C) and B-cell prolymphocytic leukaemia.
Pankaj Pande   +2 more
doaj   +1 more source

Tuberculous (TB) Meningitis and Pneumonia in a Case of Hairy Cell Leukemia Treated by 2-CDA [PDF]

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2012
Patients with lymphoproliferative disorders have cellular immune deficiency and are susceptible to typical and atypical mycobacterial infections.Hairy cell leukemia is a B-cell type lymphoproliferative disorder.2-CDA is the choice of treatment for ...
Shahin Nateghi   +2 more
doaj   +2 more sources

Subcutaneous and Intravenous Cladribine Treatment of Hairy Cell Leukemia Patients: Do We Still Need Intravenous Cladribine?

open access: yesTurkish Journal of Internal Medicine, 2023
Background Hairy cell leukemia (HCL) is an uncommon neoplasm representing approximately 2% leukemias ...
Tuba Ersal   +9 more
doaj   +1 more source

Cryocrystalglobulinemia in hairy cell leukemia [PDF]

open access: yesCancer, 1978
A patient with hairy cell leukemia (leukemic reticuloendotheliosis) was noted to have a spurious leukocytosis caused by a spontaneously crystallizing cryoglobulin. The cryoprotein was identified as IgG lambda. An intracytoplasmic immunoglobulin demonstrable within the hairy cell was also IgG lambda.
J R, Krause, P, Nitiyanant, B S, Rabin
openaire   +2 more sources

Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders

open access: yesHaematologica, 2012
Hairy cell leukemia has been shown to be strongly associated with the BRAF V600E mutation. We screened 59 unenriched archived bone marrow aspirate and peripheral blood samples from 51 patients with hairy cell leukemia using high resolution melting ...
Piers A. Blombery   +7 more
doaj   +1 more source

Hairy Cell Leukemia: the good news of a bad disease

open access: yesGalicia Clínica, 2017
Hairy Cell Leukemia (HCL) is an uncommon chronic B cell Lymphoproliferative disorder characterized by the accumulation of a small mature B cell lymphoid cells with abundant cytoplasm and “hairy” projections within the peripheral blood smear, bone marrow ...
Mónica Seidi   +2 more
doaj   +1 more source

Hairy cell leukemia and sarcoid [PDF]

open access: yesCancer, 1979
A 45-year-old female simultaneously developed both hairy cell leukemia and acute sarcoid. A defect in suppressor T lymphocytes which allowed an unrestrained B-cell proliferation manifested as both hairy cell leukemia and sarcoid is proposed.
T J, Myers, N B, Granville, B A, Witter
openaire   +2 more sources

Prognostic significance of Fc receptor-like 1 in patients with chronic lymphocytic leukemia, hairy cell leukemia, and various B-cell non-Hodgkin's lymphoma

open access: yesLeukemia Research Reports, 2019
Fc receptor-like 1 (FCRL1) positively regulates B-cell responses and may involve in the pathogenesis of B-cell malignancies. This study examined the expression pattern of FCRL1 in B-cell non-Hodgkin's lymphoma patients using real-time PCR and flow ...
Zahra Yousefi, Nahid Eskandari
doaj   +1 more source

Home - About - Disclaimer - Privacy